1. Exponentiating derivations of quasi ∗-algebras: possible approaches and applications. (27th October 2005) Authors: Bagarello, F.; Inoue, A.; Trapani, C. Journal: International journal of mathematics and mathematical sciences Issue: Number 17(2005) Page Start: 2805 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Multicomponent bulk metallic glasses with elevated-temperature resistance. (November 2019) Authors: Inoue, A.; Kong, F.L.; Zhu, S.L.; Greer, A.L. Editors: Huang, E-Wen; Liaw, Peter K. Journal: MRS bulletin Issue: Volume 44:Number 11(2019:Nov.) Page Start: 867 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Nanoporous metallic structures by de-alloying bulk glass forming Zr-based alloys. (July 2018) Authors: Mihaylov, L.; Inoue, A.; Lyubenova, L.; Nihtianova, D.; Spassov, T. Journal: Intermetallics Issue: Volume 98(2018:Jul.) Page Start: 148 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. FRI0337 Tiarp Suppresses Migration of Neutrophils into Joints VIA Down-Regulation of CXCL2/CXCR2 Pathway in Autoimmune Arthritis. (10th June 2014) Authors: Inoue, A.; Matsumoto, I.; Umeda, N.; Tanaka, Y.; Takai, C.; Kurashima, Y.; Takahashi, S.; Sumida, T. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 509 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. OP0120 Specific Identification of Anti-Citrullinated Glucose-6-Phospate Isomerase Peptide (CCG) Antibodies Associated with HLA-DRB1 SE and Disease Activity in Patients with RA. (23rd January 2014) Authors: Umeda, N.; Matsumoto, I.; Inoue, A.; Tanaka, Y.; Kondo, Y.; Tsuboi, H.; Suzuki, T.; Tsuchiya, N.; Sumida, T. Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 3(2013) Page Start: A92 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Response to the commentary by Robert Tournier and Michael Ojovan on our publication entitled "Improving glass forming ability of off-eutectic metallic glass formers by manipulating primary crystallization reactions". (December 2021) Authors: Zeng, Y.Q.; Yu, J.S.; Tian, Y.; Hirata, A.; Fujita, T.; Zhang, X.H.; Nishiyama, N.; Kato, H.; Jiang, J.Q.; Inoue, A.; Chen, M.W. Journal: Scripta materialia Issue: Number 205(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. AB0136 Clinical Aspects and Pathogenicity of Anti-Cyclic Citrullinated Glucose-6-Phospate Isomerase Peptide (CCG) Antibodies in Patients with Rheumatoid Arthritis. (10th June 2014) Authors: Umeda, N.; Matsumoto, I.; Inoue, A.; Tanaka, Y.; Takai, C.; Kurashima, Y.; Kondo, Y.; Tsuboi, H.; Ogishima, H.; Suzuki, T.; Sumida, T. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 848 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Novel heating- and deformation-induced phase transitions and mechanical properties for multicomponent Zr50M50, Zr50(M, Ag)50 and Zr50(M, Pd)50 (M = Fe, Co, Ni, Cu) amorphous alloys. (30th March 2022) Authors: Ding, J.; Inoue, A.; Kong, F.L.; Zhu, S.L.; Pu, Y.L.; Shalaan, E.; Al-Ghamdi, A.A.; Greer, A.L. Journal: Journal of materials science & technology Issue: Volume 104(2022) Page Start: 109 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. 3067 Randomized phase II trial of standard daily administration versus alternate-day administration of S-1 in patients with advanced non-small cell lung cancer: North Japan Lung Cancer Group Trial NJLCG1102. (September 2015) Authors: Saito, R.; Suzuki, A.; Maemondo, M.; Sugawara, S.; Nakagawa, T.; Taima, K.; Inoue, A.; Matsuno, K.; Usui, K.; Yokoi, T.; Kanbe, M.; Nukiwa, T. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S619 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. 3065 A phase II study of chemotherapy combined with bevacizumab for patients with malignant pleural effusions: North East Japan Lung Cancer Study Group Trial NEJ013A. (September 2015) Authors: Sugawara, S.; Usui, K.; Nishitsuji, M.; Fujita, Y.; Inoue, A.; Mouri, A.; Watanabe, H.; Sakai, H.; Kinoshita, I.; Ohhara, Y.; Maemondo, M.; Kagamu, H.; Hagiwara, K. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S618 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗